Drug Testing Locations - Refugio, TX

Drug Testing in Refugio, TX

Refugio, Texas Statistics

In 2022, there were 150 drug-related arrests in Refugio, TX, Refugio County.

Refugio County reported a 20% increase in opioid overdoses in 2021 compared to 2020.

In 2021, 35% of the admissions to local treatment centers in Refugio County were for methamphetamine abuse.

Youth drug use in Refugio County was recorded at 12% in a 2021 survey.

In 2020, Refugio's emergency services responded to 45 drug overdose calls.

How does the body eliminate Drugs

Drug elimination is the sum of the processes of removing an administered drug from the body. In the pharmacokinetic ADME scheme (absorption, distribution, metabolism, and excretion), it is frequently considered to encompass both metabolism and excretion. Hydrophobic drugs, to be excreted, must undergo metabolic modification making them more polar. Hydrophilic drugs, on the other hand, can undergo excretion directly, without the need for metabolic changes to their molecular structures.

Although many sites of metabolism and excretion exist, the chief organ of metabolism is the liver, while the organ primarily tasked with excretion is the kidney. Any significant dysfunction in either organ can result in the accumulation of the drug or its metabolites in toxic concentrations.

A variety of other factors impact elimination — intrinsic drug properties, such as polarity, size, or pKa. Also other factors include genetic variation among individuals, disease states affecting other organs, and pathways involved in the way the drug distributes through the body, such as first-pass metabolism.

Issues of Concern

Drug elimination is the removal of an administered drug from the body. It is accomplished in two ways, either by excretion of an unmetabolized drug in its intact form or by metabolic biotransformation followed by excretion. While excretion is primarily carried out by the kidneys, other organ systems are involved as well. Similarly, the liver is the primary site of biotransformation, yet extrahepatic metabolism takes place in a variety of organ systems affecting multiple drugs.

Given the multiple organ systems and the variety of metabolic transformations present, drug elimination can entail a significant degree of complexity. Hydrophilic drugs are typically directly excreted by the kidneys, while hydrophobic drugs undergo biotransformation before excretion. The purpose here is twofold – biotransformation serves both detoxify the exogenous substances as well as to increase their hydrophilicity, ensuring their elimination via the kidneys.

Two broad metabolic pathways of hepatic drug transformation exist. Phase I is the direct modification of the target molecule, whereas phase II entails conjugation of the target to a polar molecule of low molecular weight. Phase I prepare the drug to enter phase II, but single-phase metabolism also exists.

Phase I involves oxidation, reduction, and hydrolysis of the exogenous molecule. These reactions are accomplished by hepatic microsomal enzymes, which reside in the smooth endoplasmic reticulum of the hepatocytes. Best known among them is the cytochrome P450 system, whose enzymes are predominantly involved in oxidative metabolism. Within the cytochrome P450 family (CYP), the enzyme responsible for the metabolism of more than 50% of existing drugs is the CYP3A4. Its activity encompasses various classes of medications, including opioids, immunosuppressants, antihistamines, and benzodiazepines. The enzymes can also be induced or inhibited by a variety of substances they interact with, including pharmaceuticals. The increase in metabolic activity with CYP induction results in a diminished activity of drugs targeted by that particular isoform. Conversely, CYP inhibition will result in increased drug plasma concentration, potentially leading toxicity. The CYP3A4 is induced by phenytoin, phenobarbital, and St. John's wort, while diltiazem, erythromycin, and grapefruit inhibit it. Caution is, therefore, necessary when administering CYP3A4-metabolized drugs in the presence of any of the inhibitors or inducers.

Phase II consists of covalent bonding of polar groups to nonpolar molecules to render them water-soluble and allow renal or biliary excretion. Target molecules enter phase II directly or via initial processing through phase I. A variety of polar adjuncts is transferred, including amino acids, glucuronic acid, glutathione, acetate, and sulfate. Glucuronidation is one of the major pathways of phase II biotransformation. The UDP-glucuronosyltransferase (UGT) enzyme family performs this activity. Typically, glucuronide derivatives possess less or no activity of the original drug, but in some cases, pharmacologically active compounds result. Morphine-6-glucuronide is a phase II metabolite of morphine with significant analgesic activity. As with the CYP enzymes, inducers, and inhibitors of phase II, enzymes exist and may influence the efficacy of drugs that rely on conjugation before excretion.

The first-pass effect is a feature of hepatic metabolism that also plays a role in the elimination of multiple drugs. Here, the enteric consumed drugs are exposed directly to the liver via the portal vein, where they undergo biotransformation before entering the systemic circulation. This activity reduces the bioavailability and needs to be factored into the dose administered to the patient. Intravenously administered drugs are not subject to the first-pass effect.

Extrahepatic drug metabolism takes place in the GI tract, kidneys, lungs, plasma, and skin.

Renal excretion completes the process of elimination that begins in the liver. Polar drugs or their metabolites get filtered in the kidneys and typically do not undergo reabsorption. They subsequently get excreted in the urine. Urinary pH has a significant impact on excretion, as drug ionization changes depending on the alkaline or acidic environment. Increased excretion occurs with weakly acidic drugs in basic urine and weakly basic drugs in acidic urine.

Excretion in the bile is another significant form of drug elimination. The liver can actively secrete ionized drugs with a molecular weight greater than 300 g/mol into bile, from where they reach the digestive tract and are either eliminated in feces or reabsorbed as part of the enterohepatic cycle.

Other pathways of excretion include the lungs, breast milk, sweat, saliva, and tears

Employers in Refugio, TX & Drug Testing Policies

Employers in Refugio, TX, are implementing stringent drug testing policies to ensure a safe workplace. Many companies require prospective employees to undergo drug screenings before hiring, as well as random tests for current employees. The aim is to reduce workplace accidents and improve productivity levels.

Additionally, employers often provide access to counseling and support services for employees struggling with substance abuse. Among these initiatives, partnerships with organizations such as the Texas Workforce Commission help in facilitating such programs. This comprehensive approach encourages a drug-free work environment.

Government Efforts with Drug Problems in Refugio, TX

The government of Refugio, TX, in collaboration with Refugio County, has launched several initiatives to combat drug abuse. The introduction of educational programs in schools aims to inform youth about the dangers of drug use. Partnering with local law enforcement, these programs are tailored to address the community's specific needs.

Refugio County works alongside state and federal agencies, including the Texas Department of State Health Services and the Substance Abuse and Mental Health Services Administration, to secure funding for rehabilitation facilities and support services. Increased funding has enabled more comprehensive support networks for those struggling with addiction.

Local Drug Busts & News in Refugio, TX

Local authorities in Refugio, TX have been active in curbing drug trafficking and use. In a 2022 operation, Refugio County law enforcement successfully apprehended several suspects involved in a large-scale methamphetamine distribution ring. This was part of a joint effort with neighboring counties to address interstate drug flow.

Additionally, community events, such as drug awareness seminars, have been organized to educate the public on prevention strategies. These events, often held in partnership with local schools and community centers, draw large crowds, indicating increased public interest and involvement in addressing the drug issues in Refugio.

Occupational Health Services

Accredited Drug Testing offers fast, reliable employment screening services in Refugio, TX. Trusted by employers nationwide for accurate results and exceptional service.

Texas DOT/Non DOT Physicals

Texas Vision Tests

Texas Audiograms

Texas Respirator Fit Tests

Texas Lift Tests

Texas Background Checks

Clinical Testing Services

TB Testing in TX

Diabetes Testing in TX

Infectious Disease Testing in TX

Sickle Cell Anemia Testing in TX

Women/Men's Health Testing in TX

Resources & Citations

Texas Alcohol and Drug Abuse Centers

Texas Drug Rehabs

Texas Department of State Health Services

Substance Abuse and Mental Health Services Administration

Texas Health and Human Services

Mental Health and Substance Use Services

Nar-Anon Family Groups

Narcotics Anonymous

Drug Testing Near Refugio, TX

Austwell, TX

Fulton, TX

Tivoli, TX

McFaddin, TX

Cranell, TX

Bayside, TX

Holiday Beach, TX

Woodsboro, TX

Austwell-Tivoli, TX

Vidaurri, TX

Quintana, TX

Frequently Asked Questions

Customer Reviews